| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |